Search Results for "conflict of interest"
Release on psilocybin for treating depression in cancer patients strong on financial disclosures and cautions
More specifics on the degree of reduced anxiety and depression as well as a description of side effects would have been useful.
Single Dose of Hallucinogenic Drug Psilocybin Relieves Anxiety and Depression in Patients with Advanced Cancer
LA Times strikes the right balance by reporting evenly on both harms and benefits of ‘magic mushrooms’ for cancer patients
The story discusses the potential benefits in depth, which is good, but fails to quantify those benefits, which was a weak point.
Ingredient in magic mushrooms is shown to ease anxiety and depression in cancer patients in one dose
Psilocybin for treating depression in cancer patients: Informative 5-star release from Johns Hopkins
This release is very thorough in addressing benefits, potential side effects and study design in a meaningful way.
Hallucinogenic Drug Psilocybin Eases Existential Anxiety in People with Life-Threatening Cancer
STAT’s roundup of allergy treatment research needed discussion of costs
Parents curious about these forthcoming treatments are likely already wondering if they’ll be affordable, but the story skirts any discussion of pricing.
Allergy treatments enter a new era — with a focus on stopping reactions before they start
Screening frail patients before surgery: JAMA release clearly lays out benefits of intervention
But it needed information about the limitations of the study, such as the lack of a control group.
Use of Frailty Screening Initiative before Surgery Associated with Reduced Risk of Death
Release says study ‘confirms benefits’ of electro-acupuncture for hot flashes; doesn’t tell us what benefits are
The release is absent of useful details savvy readers look for when analyzing an intervention such as demonstrated benefit, cost, harms, and sponsors.
Electro-acupuncture for disrupted sleep in women with breast cancer
AP story on skin patch sweat monitor may make readers wonder: News or marketing?
The story rightly cautions that the technology is “experimental” and notes that additional research is needed. But if that’s the case, it’s not clear why this is newsworthy
SWEAT IT OUT! SKIN PATCH AIMS TO TEST SWEAT FOR HEALTH
University release takes admirably cautious approach in describing leukemia treatment response
The release makes it abundantly clear that this is a small, preliminary trial result while providing a good description of benefits and an adequate overview of the trial.
In Highly Lethal Type of Leukemia, Cancer Gene Predicts Treatment Response
Thorough WSJ report on insomnia treatments would have benefited from cost comparison
Because it lacks information on costs, readers can’t answer an important question: Can I afford it?
Can’t Get to Sleep? Lay Off the Drugs
NPR story says older patients ‘can benefit’ from lung cancer surgery, but study didn’t show that
Unfortunately the story relies more on patient anecdotes than evidence.
Older Patients Can Benefit From Lung Cancer Surgery
Novel urine test for cervical cancer: strong but could be better on false negatives
Under the best of scenarios, the new test gets it wrong 10 in 100 times. That’s a potential harm that the release didn’t call out.
Johns Hopkins Scientists Advance a Novel Urine Test to Predict High-Risk Cervical Cancer
Device for type 2 diabetes: Release prematurely touts benefits from 60-person study
More details on how this device works — as well as insights into potential cost, harms and the study limitations — would have made this a stronger release.
Development of a wearable medical device for type 2 diabetes
PR release on vitamin D and respiratory infections offers transparency on harms and study limitations
The release, however, falls short on describing costs, benefits, alternatives, and funding sources.
Vitamin D reduces respiratory infections, says CU Anschutz study
Thorough and well-done: AP story on Vivitrol injections for inmates with opioid use disorder
This story’s focus on cautionary aspects of the drug’s use and marketing does a nice job of illuminating the complexity of drug introductions.
PRISONS FIGHT OPIOIDS WITH $1,000 INJECTION: DOES IT WORK?
New statin guidelines: WaPo story wisely mentions ongoing debate about their overuse
Despite an alarmist headline, this story on statin therapy is relatively thorough, with some notable exceptions.